← Open Payments lookup

CHARLES CIOLINO: Open Payments

NPI 1841393121 · SUMMIT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,001 in 83 payments from 10 companies in 2025. Trend: 2023 $1,283 · 2024 $1,667 · 2025 $2,001

Food & beverage: $1,890Education: $111
CompanyPaymentsAmount
ABBVIE INC.29$376
Axsome Therapeutics, Inc.9$339
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$324
Teva Pharmaceuticals USA, Inc.7$293
Vanda Pharmaceuticals Inc.11$272
E.R. Squibb & Sons, L.L.C.4$160
Almatica Pharma LLC7$124
Neurocrine BioSciences, Inc.3$52
Takeda Pharmaceuticals U.S.A., Inc.3$46
Bausch Health US, LLC1$16

Products named: VRAYLAR, Auvelity, CAPLYTA, FANAPT, AUSTEDO XR, COBENFY, LOREEV XR, INGREZZA.

Industry payments across NJ — which companies pay providers there.